Recent posts

TypePostAuthorRepliesLast updated
Blog entryNIH rulemaking on transparency of clinical trials James Love05 hours 35 min ago
Blog entryUACT sends letter to Tufts President, Chairman of Trustees, asking questions about R&D cost study James Love05 hours 38 min ago
Blog entryKEI comment on the new Tufts Study on Drug Development Costs James Love01 week 1 hour ago
Blog entryThe Winning Bet Elizabeth Rajasingh01 week 1 hour ago
Blog entryResearch note on oncology drugs, including trial size and orphan drug status James Love01 week 7 hours ago
Blog entryWhat to look for in the new Tufts study on drug development costs. 10 issues. James Love01 week 9 hours ago
Blog entryKEI Research Note: Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results James Love01 week 1 day ago
Book pagePublications and Research Notes James Love01 week 1 day ago
Blog entryProposal for a WTO Agreement on the Supply of Public goods KEI Staff01 week 6 days ago
Blog entryFormer WTO Director-General, Pascal Lamy, mooted to chair Global Fund's Equitable Access Initiative thiru01 week 6 days ago
Blog entryJanuary 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer thiru02 weeks 1 day ago
PageSome news stories on cancer prices. James Love02 weeks 4 days ago
Blog entryWIPO patent committee engaged in heated talks on work sharing, limitations & exceptions, client confidentiality thiru02 weeks 5 days ago
Blog entryWIPO patent committee (SCP21): Intervention of KEI on Patents and Health thiru02 weeks 6 days ago
Blog entryWIPO patent committee (SCP21): Intervention of Pakistan on Patents and Health thiru02 weeks 6 days ago
Blog entryWIPO Standing Committee on the Law of Patents (SCP 21): Intervention of Pakistan on Opposition Systems thiru03 weeks 2 hours ago
Blog entryWIPO patent committee (SCP21) to discuss International Nonproprietary Names and Exceptions and Limitations to Patent Rights thiru03 weeks 1 day ago
Blog entryWTO TRIPS Council (October 2014): Statement of India on the Review of the Paragraph 6 system (compulsory licensing for export) thiru03 weeks 6 days ago
StoryData points on prices of medical technologies Anne Mira Guha04 weeks 2 hours ago
Blog entry28 October 2014: WTO Innovation Fair on the margins of WTO TRIPS Council review of the Paragraph 6 system thiru04 weeks 1 day ago
Blog entryObama officials seek end of WIPO program on limitations and exceptions to patent rights in developing countries Staff04 weeks 1 day ago
Book pageKEI Board of Directors KEI Staff04 weeks 4 days ago
Blog entryIndia's Department of Industrial Policy and Promotion creates IPR Think Tank to Draft National IPR Policy thiru04 weeks 4 days ago
Blog entryRajasingh on India-US dispute over patents on dasatinib, a drug to treat leukemia KEI Staff04 weeks 4 days ago
Blog entryComments to USTR on the Out-of-Cycle Review for India due October 31, 2014. KEI Staff04 weeks 4 days ago